Idarucizumab for a traumatic head injury patient taking dabigatran

BACKGROUND: Dabigatran is one of the four drugs currently used as a direct oral anticoagulant in Japan. Idarucizumab, which specifically targets dabigatran, was recently approved in Japan. We present a case of intracranial hemorrhage in a traumatic brain injury patient taking dabigatran who was trea...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Int J Emerg Med
Autori principali: Maruyama, Shuhei, Hayakawa, Koichi, Kanayama, Shuji, Iwamura, Hiromu, Wada, Daiki, Saito, Fukuki, Nakamori, Yasushi, Kuwagata, Yasuyuki
Natura: Artigo
Lingua:Inglês
Pubblicazione: Springer Berlin Heidelberg 2018
Soggetti:
Case Report
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6326148/
https://ncbi.nlm.nih.gov/pubmed/31179930
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12245-018-0202-y
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi